Search in:

Advanced search

Expert Opinion on Therapeutic Patents Volume 6, 1996 - Issue 11

Submit an article Journal homepage

Views

CrossRef citations to date

Altmetric

Research

Section Review Pulmonary-Allergy, Dermatological, Gastrointestinal & Arthritis: Recent advances in the treatment of inflammatory dermatoses

Tony C Chu Royal Postgraduate Medical School, Hammersmith Hospital, Du Cane Road, London, W12 ONN, UK

Pages 1195-1210 | Published online: 29 Feb 2008

Cite this article
https://doi.org/10.1517/13543776.6.11.1195

References
Citations
Metrics
Reprints & Permissions

References to Primarv Literature

SULZBERGER MB, WITTEN VH: The effect of topically applied compound F in selected dermatoses. J. Invest. Derrnatol. (1952) 19:101–102.
PubMed Web of Science ®Google Scholar
ELKS J: Steroid structure and steroid activity. Br. J. Dermatol. (1976) 94\(Suppl. 12):3–13.
Google Scholar
CHU AC, MUNN S: Fluticasone propionate in the treat-ment of inflammatory dermatoses. Br.J. Clin. Pharmacol. (1995) 49:131–133.
Google Scholar
KAPLAN RP, RUSSELL DH, LOWE NJ: Etretinate treatmentfor psoriasis: clinical response, remission times, epi-dermal differentiation and polyamine response. J. Am. Acad. Dermatol. (1983) 8:95–107.
PubMedGoogle Scholar
CUNLEFFE WJ, JONES DH, PRITLOVE J, PARKIN D: Longterm benefit of isotretinoin in acne; clinical and labo-ratorfy studies. In: Retinoids: New Trends in Research and Therapy. Retinoid Symposium, Geneva (1985):247–251.
Google Scholar
KRAGBALLE K: Vitamin D3 analogues. Dermatol. OM. (1995) 13:835–839.
Google Scholar
KADUNCE DP, KRUEGER GG: Pathogenesis of psoriasis: current concepts. Dermatol. Clin (1995) 13:723–737.
PubMed Web of Science ®Google Scholar
WAHLGREN CF, TENGVALL-LINDER M, HAGERMARK 0,SCHEYNIUS A: Itch and inflammation induced by intrad-ermally injected interleukin-2 in atopic dermatitis pa-tients and healthy subjects. Arch. Dermatol. Res. (1995) 287:572–580
PubMedGoogle Scholar
PRENS EP, VAN JOOST, HEGMANS JP et al: Effects ofcyclosporine and cytokine receptors in psoriasis. J. Am. Acad. Derrnatot (1995) 33:947–953
PubMedGoogle Scholar
LEMSTER BH, CARROLL PB, RILO HR et al.: IL-8/IL-8receptor expression in psoriasis and the response to systemic tacrolimus (FK506) therapy. Clin. Exp. Immu-nol. (1995) 99:148–154.
PubMed Web of Science ®Google Scholar
BERG DJ, LEACH MW, KUHN R et al.: Interleukin-10 butnot interleukin-4 is a natural suppressant of cutaneous inflammatory responses. J. Exp. Med. (1995) 182:99–108.
PubMed Web of Science ®Google Scholar
BOUILLON R, VERSTUY FA, BRANISTEANU D, WAER M,MATHIEU C: Immune modulation by vitamin D ana-logues in the prevention of autoimmune disease. Verb. K. Acad. Geneeskd. Belg. (1995) 57:371–385.
PubMedGoogle Scholar
SCHILLI MB, PAUS R, CZARNETZKI BM, REICHRATH J:Vitamin D3 and its analogues as multifunctional steroid hormones. A dermatological view of molecular and clinical aspects. Hautarzt (1994) 45:445–452.
Google Scholar
MACDONALD PN, DOWD DR, HAUSSLER MR: New insight Into the structure and functions of the vitamin D recep-tor. Semin. NephroL (1994) 14:101–118.
PubMedGoogle Scholar
CARLBERG C: The concept of multiple vitamin D signal-ing pathways J. Invest. Dermatol. (1996) 1:10–14.
Google Scholar
ICANG S, LI X-Y, VOORHEES JJ: Pharmacology and mo-lecular action of retinoids and vitamin D Laskin. J. Invest. Dermatol. (1996) 1:15–21.
Google Scholar
NORMAN AW: The vitamin D endocrine system: ma-nipulation of structure-function relationship to pro-vide opportunities for development of new cancer chemo preventative and immunosuppressive agents. J. Cell Btochem. (1995) 58\(Suppl. 221:218–225.
Google Scholar
JONES G, CALVERLEY MJ: A dialogue on analogues: newer vitamin D drugs for use in bone disease, psoriasis and cancer. Trends Endocrinol. Metab. (1993) 4:297–303.
PubMedGoogle Scholar
BAADSGAARD 0: Potential mechanism of action of vitamin D and analogues in psoriasis. Acta Derrn. Ven-ereol. (1994) 186:178–182.
Google Scholar
VAN DE KERKHOF PCM: Biological activity of vitamin Danalogues in the skin, with special reference to antip-soriatic mechanisms. Br. J. Dermatol. (1995) 132:675–682.
PubMed Web of Science ®Google Scholar
MASUDA S, STRUGNELL S, CALVERLEY MJ et al.: In vitrometabolism of anti-psoriatic vitamin D analog, cal-cipotriol, in two cultured human keratinocyte models. J. Biol. Chem. (1994) 269:4794–4803.
PubMed Web of Science ®Google Scholar
KRAGBALLE K: Calcipotriol: a new drug for topical psoriasis treatment. Pharmacol. Toxicol. (1995) 77:241–246.
PubMedGoogle Scholar
GUMOWSKI SUNEK D, RIZZOLI R, SALTRAT pi: Oral cal-cium tolerance test in extensive psoriasis treated with topical caldpotrioL Dermatology (1995) 190:43–47.
Google Scholar
BOURKE JF, BERTH-JONES J, MUMFORD R, IQBAL HUTCHINSON PE: High dose topical calcipotriol consis-tently reduces serum parathyroid hormone levels. CIO:. Endocrinot (1994) 41:295–297.
PubMed Web of Science ®Google Scholar
NISHIMURA M, MAKIN° Y, MATUGI H: Tacalcitrol oint-ment for psoriasis. Acta Derm. VenereoL (1994) 186:166–168.
Google Scholar
BAADSGAARD 0, TRAULSEN J, ROED-PETERSEN J, JAKOB-SEN HB: Optimal concentration of tacalcitrol in once daily treatment of psoriasis. J. Dermatol. Treat. (1995) 6:145–150.
Web of Science ®Google Scholar
MARTIN BOURRET V, THIVOLET J: Treatment of 15 pso-riatk patients with calcitriol per os. Nouv. Dermatol. (1995) 14:28–33.
Google Scholar
STUTTGEN G: Zur lokal behandlung von keratosen mit vitamin A saure. Dermatologica (1962) 124:65–80.
PubMedGoogle Scholar
LOGAN WS: Vitamin A and keratinisation. Arch. Derma-tol. (1972) 105:748–753.
PubMedGoogle Scholar
PLEWIG GL, KLIGMAN AM: Vitamin A in acneiform der-matoses. Acta Derm. Venereol. (1975) 55:119–127.
Google Scholar
REHTIJARVI K: Vitamin A acid in the local treatment of congenital ichthyosiform erythroderrna. Acta Derrn. Venereol (1975) 55:145–146.
Google Scholar
ALLENBY G, BOCQUEL MT, SAUNDERS M et aL: Retinoic add receptors and retinoid X receptors: interactions with endogenous retinoic acids. Rettnoids Today Tomor-row(1993) 33:23.
Google Scholar
PEDACE J, STOUGHTON R: Topical retinoic acid in acne vulgaris Br. J. Dermatol. (1971) 84:465–469.
Google Scholar
CHALKER DK, LESHER JL, GRAHAM-SMITH J et al.: Efficacy of topical isotretinoin 0.05% gel in acne vulgaris: results of a multicenter, double blind investigation./ Am. Acad. Dermatol. (1987) 17:251–254.
Google Scholar
BRAZZELL RK, VANE FM, EHMANN CW: Pharmacokinet-ics of isotretinoin during repetitive dosing to patients. Eur. J. Ctn. Pharmacol. (1983) 4:695–702.
Google Scholar
GEIGER JM, SAURAT JH: Acetretin and etretinate: how and when they should be used. Dermatol. din. (1993) 11:117–129.
Google Scholar
SHALITA A, WEISS JS, CHALKER DK et aL: A comparison of the efficacy and safety of adapakne gel 0.1% and tretinoin gel 0.025% in the treatment of acne vulgaris: a multicenter triaL J. Am. Acad. Dermatol. (1996) 34:482–485.
Google Scholar
FORD-HUTCHINSON AW: Leukotriene B4 in inflamma-tion. Crit. Rev. Immunol. (1990) 10:1–12.
PubMed Web of Science ®Google Scholar
FUNK JO, MAIBACH HI: Horizons in pharmacologic Intervention in allergic contact dermatitis. J. Am. Acad. Dermatol. (1994) 31:999–1014.
PubMed Web of Science ®Google Scholar

References to Patent Literature

LEO PHARM. PRODUCTS LTD. AS, W09319044 (1993).
Google Scholar
LEO PHARM. PRODUCTS LTD. AS, W09401398 (1994).
Google Scholar
LEO PHARM. PRODUCTS LTD. AS, W09407852 (1994).
Google Scholar
LEO PHARM. PRODUCTS LTD. AS, W09407851 (1994).
Google Scholar
LEO PHARM. PRODUCTS LTD. AS, W09410139 (1994).
Google Scholar
LEO PHARM. PRODUCTS LTD. AS, W09502577 (1995).
Google Scholar
LEO PHARM. PRODUCTS LTD. AS, W09414453 (1992).
Google Scholar
JOHNS HOPKINS UNIVERSITY, US5274142 (1993).
Google Scholar
JOHNS HOPKINS UNIVERSITY, US5403832 (1995).
Google Scholar
JOHNS HOPKINS UNIVERSITY, US 5389622 (1995).
Google Scholar
DAIKIN INDUSTRIES LTD., W09316040 (1993).
Google Scholar
DAIKIN INDUSTRIES LTD., US5206230 (1993).
Google Scholar
DAIKIN INDUSTRIES LTD., EP-529528 (1993).
Google Scholar
DAIKIN INDUSTRIES LTD., US5278155 (1994).
Google Scholar
DAIKIN KOGYO KK, JP7304732 (1995).
Google Scholar
DAIKIN KOGYO ICK, JP7304733 (1995).
Google Scholar
LABORATOIRE THERAMEX SA, W09501960 (1995).
Google Scholar
RESEARCH INST. FOR MEDICINE & CHEMISTRY, W09503273 (1995).
Google Scholar
ALLERGAN, INC., W09316029 (1993).
Google Scholar
ALLERGAN, INC., W09316067 (1993).
Google Scholar
ALLERGAN, INC., W09316068 (1993).
Google Scholar
ALLERGAN, INC., W09611686 (1996).
Google Scholar
ALLERGAN, INC., US5348975 (1994).
Google Scholar
ALLERGAN, INC., US5346915 (1994).
Google Scholar
ALLERGAN, INC., US5346895 (1994).
Google Scholar
ALLERGAN, INC., US5344959 (1994).
Google Scholar
ALLERGAN, INC., W09511242 (1995).
Google Scholar
ALLERGAN, INC., W09518803 (1995).
Google Scholar
ALLERGAN, INC., W09518120 (1995).
Google Scholar
ALLERGAN, INC., US5434173 (1995).
Google Scholar
ALLERGAN, INC., US5470999 (1995).
Google Scholar
ALLERGAN, INC., US5391753 (1995).
Google Scholar
ALLERGAN, INC., US5498795 (1996).
Google Scholar
ALLERGAN, INC., US5489584 (1996).
Google Scholar
ALLERGAN, INC., W09606070 (1996).
Google Scholar
UNIVERSITY OF HAWAII, W09221643 (1992).
Google Scholar
L'OREAL, EP-518722 (1992).
Google Scholar
LIGAND PHARM., INC., W09415902 (1994).
Google Scholar
LIGAND PHARM., INC., W09415901 (1994).
Google Scholar
LIGAND PHARM., INC., W09532946 (1995).
Google Scholar
LIGAND PHARM., INC., W09321146 (1993).
Google Scholar
PFIZER, INC., W09306086 (1993).
Google Scholar
BRISTOL-MYERS SQUIBB CO., EP-661259 (1995).
Google Scholar
BRISTOL-MYERS SQUIBB CO., EP-661261 (1995)
Google Scholar
CIBA-GEIGY AG, W09321195 (1993),
Google Scholar
CIBA-GEIGY AG, GB2282596 (1995).
Google Scholar
ALCON LABS., W09610403 (1996).
Google Scholar
EISAI CO. LTD., WP9414777 (1994).
Google Scholar
SRI INT. et al., USS466861 (1995).
Google Scholar
PIERRE FABRE COSMETIQUE, W09306818 (1993).
Google Scholar
ORTHO PHARM. CORP., EP-566405 (1993).
Google Scholar
ORTHO PHARMACEUTICAL CORP., JP100443 (1994).
Google Scholar
YAMANOUCHI EUROPE BY, W09501160 (1995).
Google Scholar
PFIZER, INC., W09315066 (1993).
Google Scholar
PFIZER, INC., W09611920 (1996).
Google Scholar
PFIZER, INC., W09611925 (1996).
Google Scholar
GD SEARLE & CO., W09221644 (1992).
Google Scholar
BOEHRINGER INGELHEIM GMBH et al,W09316036 (1993).
Google Scholar
TEVA PHARM. IND. LTD. etal., EP-544391 (1993).
Google Scholar
YEDA R&D CO. LTD., W09411006 (1994).
Google Scholar
LIGAND PHARM., INC., W09531722 (1995).
Google Scholar
SMITHKLINE BEECHAM CORP., W09513067 (1995).
Google Scholar
RES. DEVELOPMENT FDN., W09518606 (1995).
Google Scholar

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Share icon
Back to Top

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.

People also read
Recommended articles
Cited by

To cite this article:

Reference style: APA Chicago Harvard

Citation copied to clipboard

Reference styles above use APA (6th edition), Chicago (16th edition) & Harvard (10th edition)

Download citation

Download a citation file in RIS format that can be imported by citation management software including EndNote, ProCite, RefWorks and Reference Manager.

Choose format: RIS BibTex RefWorks Direct Export

Choose options: Citation Citation & abstract Citation & references

Section Review Pulmonary-Allergy, Dermatological, Gastrointestinal & Arthritis: Recent advances in the treatment of inflammatory dermatoses

References to Primarv Literature

References to Patent Literature

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Section Review Pulmonary-Allergy, Dermatological, Gastrointestinal & Arthritis: Recent advances in the treatment of inflammatory dermatoses

References to Primarv Literature

References to Patent Literature

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date